Literature DB >> 1682407

Involvement of HLA-DR+ large granular lymphocytes in the induction of tumor necrosis factor by Mycobacterium avium-intracellulare complex.

M B Michelini-Norris1, D K Blanchard, H Friedman, J Y Djeu.   

Abstract

This study shows that normal human large granular lymphocytes (LGL) secrete tumor necrosis factor (TNF) in response to Mycobacterium avium-intracellulare complex (MAI). Percoll density gradient fractionation of peripheral mononuclear cells showed TNF activity in the fractions corresponding to LGL and not T cells, even when 5% monocytes were added to the T lymphocytes for accessory function. TNF release was not abrogated by treatment of the crude LGL preparations with anti-Leu M3, -CD4, and -CD8 antibodies (Ab) plus complement (C), but was abrogated by anti-CD16 and -CD2 Ab, as expected. Interestingly, anti-HLA-DR monoclonal antibody (mAb) treatment significantly diminished TNF activity from LGL, but maintained natural killer (NK) cell function unmodified as opposed to CD2+ and CD16+ cell depletion. Panning studies demonstrated that TNF secretion upon MAI stimulation resided only in the HLA-DR+ LGL and not the DR- LGL population. These results indicate that normal fresh HLA-DR+ LGL, as well as monocytes, are also responsible for rapid TNF secretion during early MAI infection. These DR+ cells appear to be distinct from those expressing NK function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1682407     DOI: 10.1002/jlb.50.6.529

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  2 in total

1.  An alternative medium supplement for the culturing and growth of human peritoneal mesothelial cells.

Authors:  M B Michelini-Norris; J Díaz; W S Roberts; D K Blanchard; D P Barton; J Y Djeu
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

2.  Mycobacterial induction of activated killer cells: possible role of tyrosine kinase activity in interleukin-2 receptor alpha expression.

Authors:  D K Blanchard; S McMillen; S L Hoffman; J Y Djeu
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.